What ICD code is used for Congestive Heart Failure (CHF) with Chronic Kidney Disease (CKD) and Hypertension (HTN) when prescribing Amlodipine, Lisinopril, Potassium chloride, Furosemide, Aldactone (Spironolactone), and Carvedilol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Coding for CHF with Chronic Kidney Disease and Hypertension

For a patient with Congestive Heart Failure, Chronic Kidney Disease (unspecified), and Hypertension requiring multiple cardiac medications, the appropriate primary ICD-10 code is I13.0 (Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease).

Rationale for Code Selection

The medications prescribed (Amlodipine, Lisinopril, Potassium chloride, Furosemide, Aldactone, and Carvedilol) indicate treatment for a combination of:

  1. Heart failure (treated with Lisinopril, Furosemide, Aldactone, and Carvedilol)
  2. Hypertension (treated with Amlodipine, Lisinopril, and Carvedilol)
  3. Chronic kidney disease (managed with careful medication selection)

Code Breakdown:

  • I13.0 - This is the appropriate combination code that captures all three conditions:
    • Hypertensive heart disease with heart failure
    • Chronic kidney disease
    • Heart failure

This single code is more appropriate than using separate codes because:

  • The conditions are clinically related
  • Guidelines recommend using combination codes when available 1
  • The medications prescribed address this specific disease complex

Secondary Codes

You may need to add secondary codes to further specify:

  • N18.9 - Chronic kidney disease, unspecified (if stage is not documented)
  • I50.9 - Heart failure, unspecified (if type of heart failure is not specified)

Medication-Specific Coding Considerations

Each medication in the list corresponds to the treatment of this disease complex:

  • Amlodipine: Calcium channel blocker for hypertension 1
  • Lisinopril: ACE inhibitor for heart failure and hypertension 1
  • Potassium chloride: Supplement to prevent hypokalemia from diuretic therapy 1
  • Furosemide: Loop diuretic for fluid overload in heart failure 1
  • Aldactone (Spironolactone): Aldosterone antagonist for advanced heart failure 1
  • Carvedilol: Beta-blocker for heart failure management 1

Important Clinical Considerations

  • Monitor renal function closely as both ACE inhibitors (Lisinopril) and aldosterone antagonists (Spironolactone) can affect kidney function 2, 3
  • Regular potassium monitoring is essential due to the combination of Lisinopril, Spironolactone, and Potassium chloride 3
  • If the patient's kidney function worsens significantly, medication adjustments may be necessary, which could affect coding 4, 5

Documentation Tips for Accurate Coding

For more specific coding in the future, ensure documentation includes:

  • Specific stage of CKD (1-5)
  • Type of heart failure (systolic, diastolic, combined)
  • Whether heart failure is acute, chronic, or acute on chronic
  • Relationship between hypertension and heart/kidney disease

This approach ensures the most accurate representation of the patient's condition for both clinical care and billing purposes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Heart failure and chronic kidney disease: should we use spironolactone?

The American journal of the medical sciences, 2015

Research

Hypertension in chronic kidney disease-treatment standard 2023.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.